HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rash Of FDA Warning Letters Raises Questions For Cosmetics Industry

This article was originally published in The Rose Sheet

Executive Summary

EAS Consulting rep John Bailey, who directed FDA’s cosmetics program in the 1990s and served as PCPC chief scientist through July of 2011, offers his view on the six warning letters issued to cosmetics firms between Sept. 7 and Oct. 5. It’s too early to say whether FDA is taking a more aggressive stance on cosmetics claims, but firms “need to be aware,” Bailey says.

Advertisement

Related Content

FDA Clampdown On Excessive Anti-Aging Claims May Lighten Up In 2017
What Comes First In Consumer Sector: FDA Excessive Claims Finding Or Facility Inspection?
What Comes First In Consumer Sector: FDA Excessive Claims Finding Or Facility Inspection?
What Comes First? FDA Excessive Claims Finding Or Facility Inspection?
What Comes First In FDA Land, Excessive Claims Finding Or Facility Inspection?
Regulatory Roulette: Playing In Today’s Skin-Care Market A Gamble
FDA Serves Up More Warnings: Avon Cited For Touting Druglike Benefits
FDA Warns Lancome For Gene/Stem-Cell Claims: A Signal To Marketplace?
Universe Of Skin Care Targeting Stem Cells, DNA Continues To Grow
Lauder Synchronizes Genetic Skin Cell Clocks For Optimal Night Repair

Topics

Advertisement
UsernamePublicRestriction

Register

RS018325

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel